| Document Date: 2013-09-27 09:05:29
Open Document File Size: 592,60 KBShare Result on Facebook
City San Francisco / Atlanta / Seattle / Francisco / Detroit / / Country United States / / Facility National Cancer Institute / / IndustryTerm active surveillance follow-up protocol / resonance imaging / treatment of 3 prostate cancer / prostate cancer treatment / / MedicalCondition cancers / tumor / detected tumors / chronic illnesses / very low risk tumors / common cancer / cancer / tumors / Disease / low-risk prostate cancer / symptomatic disease / urinary incontinence / prostate cancers / clinical significant tumors / risk cancers / advanced cancer / metastatic disease / pain / localized prostate cancer / particular individual’s cancer / clinically localized disease / Each tumor / Prostate cancer / impotence / / MedicalTreatment surgery / radiation / / Organization National Cancer Institute / National Institute of Health / Federal Government / Agency for Healthcare / office of Medical Applications of Research / / Position physician / representative / / ProvinceOrState New Mexico / Utah / Hawaii / Iowa / Connecticut / / Technology active surveillance follow-up protocol / 12 13 Follow-up Protocols / radiation / MRI / 14 15 Follow-up Protocol / /
SocialTag |
DRAFT STATEMENT December 7, 2011 1:45 AM NATIONAL INSTITUTES OF HEALTH CONSENSUS DEVELOPMENT CONFERENCE STATEMENT National Institutes of Health State-of-the-Science Conference: